The Safety And Efficacy Of Maintenance Therapy With CP-690,550
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This study investigates safety and efficacy of CP-690,550 in adult patients with moderate to
severe Crohn's disease who completed the double-blind induction treatment in Study A3921083
and achieved clinical response-100 and/or clinical remission (CDAI<150) at Week 8.